Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (5) Apply Yes filter

Referral type

Article 30 referrals Remove Article 30 referrals filter Article 20 procedures Remove Article 20 procedures filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter Article 29(4) referrals (116) Apply Article 29(4) referrals filter Article 31 referrals (100) Apply Article 31 referrals filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 107i procedures (5) Apply Article 107i procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (18) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (20) Apply Centrally authorised product(s) filter Nationally authorised product(s) (2) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (2) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

127 results

Remove all filtersRemove all filters

Keyword Remove keyword

Medicine Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter

Referral type Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 30 referrals Remove Article 30 referrals filter Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter Article 20 procedures Remove Article 20 procedures filter

Categories Human Remove Human filter

Sort by

List item

Referral: Zinbryta

daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018, Last updated: 11/07/2018
List item

Referral: Cozaar Comp

losartan + hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008
List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Agopton

Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006
List item

Referral: Amoxil

amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016
List item

Referral: Arimidex

anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011
List item

Referral: Atacand

candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011
List item

Referral: Atacand Plus

candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011
List item

Referral: Augmentin

amoxicillin and clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013
List item

Referral: Belanette

Drospirenone + Ethinylestradiol, Article 5(11) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 14/12/2007, EC decision date: 17/06/2008, Last updated: 03/07/2008
List item

Referral: Bupropion hydrochloride

bupropion, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 25/07/2002, EC decision date: 25/10/2002, Last updated: 06/12/2002
List item

Referral: Calcichew D3

Calcium 500 mg / cholecalciferol 10 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004
List item

Referral: Calcichew D3 mite

Calcium 500 mg / cholecalciferol 5 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004
List item

Referral: Calcitugg

Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004
List item

Referral: Calcium Sandoz

Calcium lactate gluconate, Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 09/08/2005, Last updated: 09/08/2005
List item

Referral: Cerivastatin

cerivastatin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/03/2002, EC decision date: 22/08/2002, Last updated: 20/12/2002
List item

Referral: Ciprofloxacin Bayer

ciprofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 07/10/2008, Last updated: 23/10/2008
List item

Referral: Clenil and associated names

beclometasone dipropionate, associated names: Becloneb, Beclospin and Sanasthmax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/09/2016, EC decision date: 11/11/2016, Last updated: 18/11/2016
List item

Referral: Corlentor and Procoralan

ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015
List item

Referral: Coversyl

Perindopril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 04/12/2003, Last updated: 23/12/2003
List item

Referral: Cozaar

losartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008
List item

Referral: Cymevene

ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016
List item

Referral: Daivobet

calcipotriol and betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011
List item

Referral: Diflucan

fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012
List item

Referral: Diovan

valsartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 16/02/2009, Last updated: 13/03/2009

Load more

127 results

Referral: Zinbryta

Referral: Cozaar Comp

Referral: Picato

Referral: Agopton

Referral: Amoxil

Referral: Arimidex

Referral: Atacand

Referral: Atacand Plus

Referral: Augmentin

Referral: Belanette

Referral: Bupropion hydrochloride

Referral: Calcichew D3

Referral: Calcichew D3 mite

Referral: Calcitugg

Referral: Calcium Sandoz

Referral: Cerivastatin

Referral: Ciprofloxacin Bayer

Referral: Clenil and associated names

Referral: Corlentor and Procoralan

Referral: Coversyl

Referral: Cozaar

Referral: Cymevene

Referral: Daivobet

Referral: Diflucan

Referral: Diovan